Abstract
BACKGROUND: Dermatological Adverse drug reactions are one of the most common leading causes of morbidity and mortality. The increasing cause of ADR may diminished quality of life, increased physician visit, hospitalization and even death. Pharmacovigilence service is needed to increase the ADR reporting system MATERIALS AND METHODS: A prospective observational study carried out at Department of Dermatology at RIMS, kadapa over a period of six months. The inclusion criteria of the study were patients of all age groups with both genders, presenting in department of dermatology. Pregnant women were excluded in the study. Causality of ADRs was evaluated assessment scale such as Naranjo’s scale, WHO scale etc. RESULT: A total of 1963 study population, 169 patients with Drug related problem were screened. Among 8 drug related class, Adverse drug reaction 83(49.11%)is highly occurred in our study. out of 169 DRP’s ,83 ADR cases were found. The most suspected ADR were Skin rashes/lesions/eruption. There were four different intervention done against the suspected drug which were drug discontinuation15 (8.87%), Antidote given 107 (63.31%),time gap (30min to 1hr) between one drug to other36(21.0%), dose tapered 11(6.51%). CONCLUSION: Clinical pharmacist should be responsible to provide awareness to the health care system for the importance of ADR monitoring and reporting thereby improving the quality of life public health.
